Alector (STU:0Z2) FFO


STU:0Z2 Alector Inc STU:0Z2
31 GF Score
Price €1.78
GF Value €0.63
! 7 Warning Signs
View Full Analysis

What is Alector FFO?

FFO (Funds from operations) only applies to REITs.

STU:0Z2
31GF Score
Alector Inc STU:0Z2
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alector (STU:0Z2) Overvalued in 2026?

Based on GuruFocus' analysis, Alector stock appears to be overvalued. The current stock price of €1.78 is trading 182.4% above its estimated GF Value™ of €0.63.

Key valuation signals for STU:0Z2:

  • FFO:
  • GF Value™: €0.63 vs. price of €1.78 (182.4% above fair value)
  • GF Score™: 31/100 with 7 warning signs

No single metric tells the full story. See the STU:0Z2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alector Business Description

Other Exchanges ALEC:USA
Address 131 Oyster Point Boulevard, Suite 600, South San Francisco, CA, USA, 94080
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
31GF Score

Get the complete analysis for STU:0Z2

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.78
Price
€0.63
GF Value